Global Cardiac Markers Point-of-care Detection Market Growth (Status and Outlook) 2023-2029

Global Cardiac Markers Point-of-care Detection Market Growth (Status and Outlook) 2023-2029

The global Cardiac Markers Point-of-care Detection market size is projected to grow from US$ 3423.9 million in 2022 to US$ 6311 million in 2029; it is expected to grow at a CAGR of 9.1% from 2023 to 2029.

The cardiac marker point-of-care testing market has witnessed significant growth in recent years, driven by rising prevalence of cardiovascular diseases, advancements in POC technology, and emphasis on personalized medicine.

The immediate detection of cardiac markers is mainly a rapid quantitative or qualitative detection and screening of common cardiovascular diseases, including rapid detection reagents and quantitative analysis instruments such as myocardial injury markers, heart failure markers, platelet function and coagulation mechanism.

LPI (LP Information)' newest research report, the “Cardiac Markers Point-of-care Detection Industry Forecast” looks at past sales and reviews total world Cardiac Markers Point-of-care Detection sales in 2022, providing a comprehensive analysis by region and market sector of projected Cardiac Markers Point-of-care Detection sales for 2023 through 2029. With Cardiac Markers Point-of-care Detection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cardiac Markers Point-of-care Detection industry.

This Insight Report provides a comprehensive analysis of the global Cardiac Markers Point-of-care Detection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cardiac Markers Point-of-care Detection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cardiac Markers Point-of-care Detection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cardiac Markers Point-of-care Detection and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cardiac Markers Point-of-care Detection.

This report presents a comprehensive overview, market shares, and growth opportunities of Cardiac Markers Point-of-care Detection market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Medical Equipment
Consumables

Segmentation by application
Hospital
Clinic
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Alere
Roche
Abbott
BioMérieux
LSI Medience Corporation
Randox laboratories Ltd
Guangzhou Wondfo Biotechnology Co., Ltd.
Getein Biotech
ReLIA
Lepu Medical
Goldsite
Lifotronic
Hotgen
Ediagnosis
POCT

Please note: The report will take approximately 2 business days to prepare and deliver.